Breaking News - The Fly

Open Search

OTLK

Outlook Therapeutics

$

()

Outlook Therapeutics announces NICE recommendation of LYTENAVA

OTLK

12/4/2024 - 08:09am

Outlook Therapeutics CEO Russell Trenary steps down

OTLK

12/3/2024 - 16:32pm

Outlook Therapeutics just downgraded at Chardan, here's why

OTLK

12/2/2024 - 04:50am

Unusually active option classes on open November 29th

K , OTLK , RF

…

11/29/2024 - 09:40am

Outlook Therapeutics price target lowered by $41 at BTIG, here's why

OTLK

11/29/2024 - 05:48am

Outlook Therapeutics reports preliminary results from Norse Eight trials

OTLK

11/27/2024 - 06:53am

Outlook could disrupt ocular anti-VEGF injection market, says BTIG

OTLK

10/18/2024 - 11:23am

JMP Securities healthcare analysts hold an analyst/industry conference call

CLSD , OCUL , EYPT

…

9/18/2024 - 04:55am

JMP Securities healthcare analysts hold an analyst/industry conference call

CLSD , OCUL , EYPT

…

9/13/2024 - 15:07pm

Outlook Therapeutics announces completion of enrollment in NORSE EIGHT trial

OTLK

9/4/2024 - 08:37am

Outlook Therapeutics reports Q3 adjusted EPS (83c), consensus ($1.01)

OTLK

8/14/2024 - 07:20am

Unity Biotechnology appoints Tozier as Chief Strategy Officer

UBX , OTLK

7/22/2024 - 08:11am

Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA

OTLK

7/8/2024 - 08:40am

Outlook Therapeutics management to meet virtually with BTIG

OTLK

7/2/2024 - 05:55am

Outlook Therapeutics management to meet virtually with BTIG

OTLK

7/1/2024 - 04:55am